Cargando…

Comprehensive assay of kinase catalytic activity reveals features of kinase inhibitor selectivity

Small-molecule protein kinase inhibitors are central tools for elucidating cellular signaling pathways and are promising therapeutic agents. Due to evolutionary conservation of the ATP-binding site, most kinase inhibitors that target this site promiscuously inhibit multiple kinases. Interpretation o...

Descripción completa

Detalles Bibliográficos
Autores principales:	Anastassiadis, Theonie, Deacon, Sean W., Devarajan, Karthik, Ma, Haiching, Peterson, Jeffrey R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2011
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3230241/ https://www.ncbi.nlm.nih.gov/pubmed/22037377 http://dx.doi.org/10.1038/nbt.2017

Ejemplares similares

Comprehensive kinase profile of pacritinib, a nonmyelosuppressive Janus kinase 2 inhibitor
por: Singer, Jack W, et al.
Publicado: (2016)

Ushering in the era of tRNA medicines
por: Anastassiadis, Theonie, et al.
Publicado: (2023)

Conformational Analysis of the DFG-Out Kinase Motif and Biochemical Profiling of Structurally Validated Type II Inhibitors
por: Vijayan, R. S. K., et al.
Publicado: (2014)

Crystal Structures of the p21-Activated Kinases PAK4, PAK5, and PAK6 Reveal Catalytic Domain Plasticity of Active Group II PAKs
por: Eswaran, Jeyanthy, et al.
Publicado: (2007)

Characterization of Isoenzyme-Selective Inhibitors of Human Sphingosine Kinases
por: Gao, Peng, et al.
Publicado: (2012)

Quantitative conformational profiling of kinase inhibitors reveals origins of selectivity for Aurora kinase activation states
por: Lake, Eric W., et al.
Publicado: (2018)

A Homogenous Luminescence Assay Reveals Novel Inhibitors for Giardia Lamblia Carbamate Kinase
por: Chen, Catherine Z, et al.
Publicado: (2012)

Cytoprotective effect of selective small-molecule caspase inhibitors against staurosporine-induced apoptosis
por: Wu, Jianghong, et al.
Publicado: (2014)

Developing selective histone deacetylases (HDACs) inhibitors through ebselen and analogs
por: Wang, Yuren, et al.
Publicado: (2017)

Structural basis for the substrate specificity and catalytic features of pseudouridine kinase from Arabidopsis thaliana
por: Kim, Sang-Hoon, et al.
Publicado: (2020)

Phospho-kinase profile of colorectal tumors guides in the selection of multi-kinase inhibitors
por: Serrano-Heras, Gemma, et al.
Publicado: (2015)

Catalytic Specificity of Human Protein Tyrosine Kinases Revealed by Peptide Substrate Profiling
por: Blouin, Julie, et al.
Publicado: (2011)

Comprehensive analysis of T cell leukemia signals reveals heterogeneity in the PI3 kinase-Akt pathway and limitations of PI3 kinase inhibitors as monotherapy
por: Ksionda, Olga, et al.
Publicado: (2018)

Myelosuppression and kinase selectivity of multikinase angiogenesis inhibitors
por: Kumar, R, et al.
Publicado: (2009)

KInhibition: A Kinase Inhibitor Selection Portal
por: Bello, Thomas, et al.
Publicado: (2018)

Clinical significance of Janus Kinase inhibitor selectivity
por: Choy, Ernest H
Publicado: (2019)

Clinical significance of Janus Kinase inhibitor selectivity
por: Choy, Ernest H
Publicado: (2019)

Targeting Kinases in Fasciola hepatica: Anthelminthic Effects and Tissue Distribution of Selected Kinase Inhibitors
por: Morawietz, Carolin M., et al.
Publicado: (2020)

Reconciling Selectivity Trends from a Comprehensive Kinase Inhibitor Profiling Campaign with Known Activity Data
por: Miljković, Filip, et al.
Publicado: (2018)

A Fluorescence-Based Thermal Shift Assay Identifies Inhibitors of Mitogen Activated Protein Kinase Kinase 4
por: Krishna, Sankar N., et al.
Publicado: (2013)

Comprehensive profiling of the STE20 kinase family defines features essential for selective substrate targeting and signaling output
por: Miller, Chad J., et al.
Publicado: (2019)

PROTAC-mediated degradation reveals a non-catalytic function of AURORA-A kinase
por: Adhikari, Bikash, et al.
Publicado: (2020)

KIDFamMap: a database of kinase-inhibitor-disease family maps for kinase inhibitor selectivity and binding mechanisms
por: Chiu, Yi-Yuan, et al.
Publicado: (2013)

Selectivity Profile of the Tyrosine Kinase 2 Inhibitor Deucravacitinib Compared with Janus Kinase 1/2/3 Inhibitors
por: Chimalakonda, Anjaneya, et al.
Publicado: (2021)

Optimization of Luminescent Assay for Screening of Cyclin-Dependent Kinase 2 Inhibitors
por: Suthar, M. P., et al.
Publicado: (2010)

Evaluation of a tyrosine kinase peptide microarray for tyrosine kinase inhibitor therapy selection in cancer
por: Labots, Mariette, et al.
Publicado: (2016)

Comprehensive Kinase Activity Profiling Revealed the Kinase Activity Patterns Associated with the Effects of EGFR Tyrosine Kinase Inhibitor Therapy in Advanced Non-Small-Cell Lung Cancer Patients with Sensitizing EGFR Mutations
por: Noguchi, Rei, et al.
Publicado: (2023)

Evolution of an adenocarcinoma in response to selection by targeted kinase inhibitors
por: Jones, Steven JM, et al.
Publicado: (2010)

Correction: A Fluorescence-Based Thermal Shift Assay Identifies Inhibitors of Mitogen Activated Protein Kinase Kinase 4
por: Krishna, Sankar N., et al.
Publicado: (2013)

Anaplastic Lymphoma Kinase (ALK) Receptor Tyrosine Kinase: A Catalytic Receptor with Many Faces
por: Huang, Hao
Publicado: (2018)

Structures of Helicobacter pylori Shikimate Kinase Reveal a Selective Inhibitor-Induced-Fit Mechanism
por: Cheng, Wen-Chi, et al.
Publicado: (2012)

Computational Study of Gleevec and G6G Reveals Molecular Determinants of Kinase Inhibitor Selectivity
por: Lin, Yen-Lin, et al.
Publicado: (2014)

The Kinase Specificity of Protein Kinase Inhibitor Peptide
por: Chen, Yao, et al.
Publicado: (2021)

The dimer-dependent catalytic activity of RAF family kinases is revealed through characterizing their oncogenic mutants
por: Yuan, Jimin, et al.
Publicado: (2018)

An insight into lung cancer: A comprehensive review exploring anaplastic lymphoma kinase tyrosine kinase inhibitors and mechanisms of resistance
por: Pătcaş, Adela, et al.
Publicado: (2022)

Targeting HER3, a Catalytically Defective Receptor Tyrosine Kinase, Prevents Resistance of Lung Cancer to a Third-Generation EGFR Kinase Inhibitor
por: Romaniello, Donatella, et al.
Publicado: (2020)

The highly selective Bruton tyrosine kinase inhibitor acalabrutinib leaves macrophage phagocytosis intact
por: Pinney, Jonathan J., et al.
Publicado: (2022)

Selective Mycobacterium tuberculosis Shikimate Kinase Inhibitors as Potential Antibacterials
por: Gordon, Sara, et al.
Publicado: (2015)

Discovery of a selective inhibitor of Doublecortin Like Kinase 1
por: Ferguson, Fleur M., et al.
Publicado: (2020)

Impact of Selected Small-Molecule Kinase Inhibitors on Lipid Membranes
por: Luck, Meike, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_5dlbp3r1fiunnqhlh9mg0o1lul